PYRIMIDINVERBINDUNG ODER SALZ DAVON

European patent · EP3909584 · In force

Register entry

Publication number
EP3909584
Application number
EP20737875
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 10, 2020
Published
Nov 17, 2021
Granted
Dec 13, 2023
Protection ends at the latest
Jan 9, 2040
Next annual fee due
Jan 31, 2027
IPC classes
C07D 487/04 (2006.01)
A61K 31/519 (2006.01)
A61P 35/00 (2006.01)
A61P 43/00 (2006.01)
C12N 15/54 (2006.01)
Priority
JP 2019003403 11.01.2019
PCT application
PCT/JP2020/000592 10.01.2020
PCT publication
WO2020/145374 16.07.2020
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  3. Oct 23, 2024

    Change

    Published in Swissreg on 23.10.2024

  4. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  5. Jan 3, 2024

    Agent entered

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 03.01.2024

  6. Dec 13, 2023

    Granted

    Published in Swissreg on 13.12.2023

Parties

Holder

TAIHO PHARMACEUTICAL CO., LTD.

Taiho Pharmaceutical Co., Ltd.

1-27 Kandanishiki-cho, Chiyoda-ku Tokyo 101-8444, JP

Agent

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventor

NAKAMURA Masayuki

Tsukuba-shi, Ibaraki 300-2611, JP

ASAI Takahiro

Tsukuba-shi, Ibaraki 300-2611, JP

OGUCHI Kei

Tsukuba-shi, Ibaraki 300-2611, JP

IGUCHI Satoru

Tsukuba-shi, Ibaraki 300-2611, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.